Eyebright Medical Technology Financials

Market Capitalization CN¥17.44 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	47.17
Forward PE	33.82
Price to Sales TTM	CN¥12.84
Price to Book MRQ	CN¥7.48
Enterprise to Revenue	13.24
Enterprise to EBITDA	35.51

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	27.21%
Operating Margin	33.14%
Return on Assets TTM	8.72%
Return on Equity TTM	14.76%

Income Statement

Revenue TTM	CN¥1,358,345,216
Revenue per Share TTM	CN¥7.19
Quarterly Revenue Growth	49.10%
Gross Profit TTM	CN¥722,946,093
EBITDA	CN¥447,194,183
Net Income to Common TTM	CN¥369,600,032
Diluted EPS TTM	CN¥1.95
Quarterly Earnings Growth YoY	23.40%

Balance Sheet

Total Cash MRQ	CN¥469,250,272
Total Cash per Share MRQ	CN¥2.48
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	24.68
Current Ratio MRQ	4.76
Book Value per Share MRQ	CN¥12.29

Cash Flow

Operating Cash Flow TTM	CN¥298,914,976
Levered Free Cash Flow TTM	CN¥-375,495,584

688050 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	189,544,992
Float Shares	123,177,407
Avg 10 Volume	2,014,789
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	38.48%
% Held by Institutions	20.79%

Stock Price Summary

Beta	0.52
Fifty Two Week Low	CN¥65.17
Fifty Two Week High	CN¥170.71
Fifty Two Week Change	-48.79%
Day 50 MA	CN¥95.52
Day 200 MA	CN¥102.60

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.96
Forward Annual Dividend Yield	1.97%
Trailing Annual Dividend Rate	CN¥0.49
Trailing Annual Dividend Yield	0.49%
Payout Ratio	25.13%
Dividend Date
Ex Dividend Date	2024-06-05
Last Split Factor
Last Split Date	2024-06-05